Nova Biomedical fait progresser les processus intégrés de développement de lignées cellulaires : les produits de NanoCellect entrent dans la gamme de Nova Biomedical

Positive

AI Analysis

Summary

Nova Biomedical announced an acquisition of certain assets from NanoCellect, a microfluidic cell sorting technology provider, to expand its cell line development capabilities.

Importance:5/10

Sentiment:

0.50

acquisitioncell line developmentmicrofluidic technologycell sorting

Read the original article

Published by PR Newswire Biotech on July 24, 2026 5:48 PM

Read Original